8 April 2021
"As a scientist, I’m really excited about that because it means that we’re bringing truthful scientific information to people..."
Below is the transcript of the video:
The regulation of combusted cigarettes and IQOS, which in the U.S. is classified as a non-combusted cigarette, is quite different. For example, IQOS has different health warnings compared to combusted cigarettes. And also now, because of the modified risk tobacco product authorization, we can now bring reduced exposure messages to adult smokers to help guide their choices. As a scientist, I’m really excited about that because it means that we’re bringing truthful scientific information to people who oftentimes otherwise would just continue to smoke. So, I think it’s going to be really important to help those people make better choices.
Through the MRTP pathway the FDA completed its scientific review of PMI's scientific evidence package—and independent studies—and decided that issuing an exposure modification order for IQOS is appropriate to promote the public health and is expected to benefit the health of the population as a whole. In reaching its decision, FDA had to consider not only the scientific evidence, but also the context and strictures imposed by U.S. law and regulations. The provisions of the 2009 Family Smoking Prevention and Tobacco Control Act set a standard specific to the U.S. and FDA must work within the framework that the law sets out.
The FDA's decision provides an important example of a government regulating smoke-free alternatives differently from combustible cigarettes based on their risk profile. The information in the video does not, and is not intended to, constitute legal advice.
Smoke-free products are for adult smokers who would otherwise continue smoking. They are not risk-free and contain nicotine, which is addictive. The best choice any smoker can make is to quit cigarettes and nicotine altogether.